Return to search

EUSA Pharma Buys OPi SA

EUSA Pharma Inc., a specialty pharma company focused on the hospital market, has agreed to acquire French drug company OPi SA. The acquisition is being backed by $175 million in financing co-led by 3i Group and Essex Woodlands Health Ventures. Other backers include Goldman Sachs, Advent Venture Partners, NeoMed and NovaQuest. EUSA Pharma was formed in May 2006 with $53 million from Essex Woodlands, after which it acquired Talisker Pharma, which had a pair of CNS products.